EVENTS ANNOUNCEMENT
Future Investments Circle in Dubai
Before we let you get to this week’s newsletter, we have a short announcement for you.
This September, the Future Investments Circle heads to Dubai, together with AIM Congress. Following our debut in Davos during the World Economic Forum, we're bringing our curated, closed-door investor gathering to the region on 7 September — with a focus on the space economy, robotics, and longevity. Places are limited and by application.
Now onto this week’s stories.
FUSION & FISSION ENERGY
Thea Energy Tops Up Its Series B as the Stellarator Race Heats Up
Thea Energy has closed an extension to its Series B, drawing in Brevan Howard Macro Venture, Aloniq, ALJ Investments, and Beyond Earth Ventures on top of the $100M round it raised in May. The Princeton spinout is betting on a planar-coil stellarator built from mass-manufacturable magnets and software control, and is channeling the fresh capital into magnet production lines and its Eos fusion system. The extension amount was undisclosed.
What happened
Thea closed a Series B extension with Brevan Howard Macro Venture, Aloniq, ALJ, and Beyond Earth Ventures joining.
It builds on the $100M Series B led by Thomas Tull's US Innovative Technology Fund in May.
Capital targets modular HTS magnet production and its Eos integrated system; the amount wasn't disclosed.
Why it matters
Thea's software-defined, mass-manufacturable magnet approach reframes fusion as a manufacturing problem, not only a physics one.
Its Helios plant design was DOE-certified under the Milestone-Based Fusion Development Program.
The raise signals continued private appetite for fusion even at pre-revenue, capital-intensive stages.
For investors
Thea offers exposure to the stellarator lane, distinct from tokamak and inertial approaches.
Marquee crossover names like Brevan Howard entering suggest fusion is pulling in generalist capital.
Risk: the undisclosed round size limits read-through, and commercial power remains a next-decade prospect.
Read more: energynews.pro (August 18, 2026)
NEXT-GEN ENERGY
Radiant Trucks Its Microreactor to the Only Full-Power Test Bed in the US
Radiant's Kaleidos, a 1 MWe transportable microreactor, has reached Idaho National Laboratory's DOME facility for what the company calls the industry's only full-scale, full-power microreactor test. After a 1,000-mile road trip on a trailer, the helium-cooled, TRISO-fueled unit will run a five-phase campaign from zero-power criticality to a 150-hour continuous run — the same design Radiant plans to mass-produce at its Oak Ridge factory and ship to customers by 2028.
What happened
Radiant delivered its 1 MWe Kaleidos microreactor to INL's DOME after a 1,000-mile road move.
It will be the first reactor to go critical in DOME in decades, running a five-phase full-power test.
The unit is the same design and fuel load destined for Radiant's Oak Ridge R-50 production line.
Why it matters
A full-scale, full-power test — not a sub-scale article — is a hard de-risking step most peers haven't reached.
Test data feeds directly into Radiant's NRC licence application, targeted for late 2026.
Transportable microreactors target off-grid, military, and data-center power; Radiant has a 2028 Air Force delivery.
For Investors
Radiant is a private, mass-manufacturing bet on microreactors as a product, not a one-off project.
The Air Force agreement (Buckley Space Force Base) gives it an anchor customer ahead of commercial scale.
Risk: pre-licence and pre-revenue; the campaign must clear all five phases to validate the model.
Read more: World Nuclear News (August 18, 2026)
FUSION & FISSION ENERGY
The First Public Fusion Company Lands Its First Commercial Framework
General Fusion, which became the first publicly listed fusion company after a July SPAC merger, used its first business update to unveil a milestone-based framework agreement with Italy's Renexia for potential commercial deployment, plus a diagnostics partnership with General Atomics. The Vancouver-based company — pursuing magnetized target fusion — holds roughly $150M to push its LM26 machine toward the plasma conditions needed for net energy.
What happened
General Fusion announced a milestone-based framework with Renexia (Toto Group) for potential deployment in Italy.
It added a General Atomics collaboration on plasma diagnostics above 10 keV.
The update follows its July Nasdaq listing (~$150M cash) via SPAC; LM26 has reached ~8.4M°C en route to 1 keV.
Why it matters
A commercial framework, however preliminary, is a rare signal of customer pull in pre-net-energy fusion.
Magnetized target fusion avoids superconducting magnets and lasers — a differentiated cost thesis.
As the first public fusion pure-play, General Fusion sets a visible valuation benchmark for the field.
For Investors
General Fusion is now publicly listed (GFUZ) — a liquidity and benchmark signal, not a private entry.
Its runway funds LM26 milestones only through 2028, well short of a commercial plant (~2035 target).
Risk: the Renexia deal is a non-binding framework, and net energy remains unproven for MTF.
Read more: General Fusion (August 18, 2026)
QUANTUM COMPUTING
IBM Cools the Plumbing for a Fault-Tolerant Machine
IBM has connected and cooled two cryogenic modules into a single sub-15-millikelvin environment — the refrigeration backbone it will need to link hundreds of quantum chips. The milestone advances IBM's roadmap toward Starling, the fault-tolerant quantum computer it aims to deliver in 2029. Combined, the modules stand more than eight feet tall and reached near-absolute-zero in under five days, with Nighthawk processors due to be installed later this year.
What happened
IBM joined two cryogenic modules into one system cooled to below 15 millikelvin.
The modules stand 8+ feet tall and reached 4 Kelvin in under five days.
It's a step toward IBM Quantum Starling (2029), IBM's planned first fault-tolerant machine.
Why it matters
Scaling to hundreds of chips needs shared ultra-cold infrastructure — the unglamorous bottleneck IBM just tackled.
IBM's 2027 milestone (L-couplers, 1,000+ programmable qubits) now looks on track.
Progress from a roadmap leader de-risks timelines for the whole fault-tolerance thesis.
For investors
IBM is publicly listed (NYSE: IBM) — read this as sector timing, not a private entry.
On-schedule progress pulls forward the commercial window for quantum-adjacent private plays (cryogenics, control, software).
Risk: 2029 is still years out, and engineering milestones don't guarantee quantum advantage on real problems.
Read more: IBM (August 19, 2026)
PARTNER SPOTLIGHT
EYWA by R.Evolution × Longevity Investors
EYWA by R.Evolution is a global regenerative real estate brand redefining what it means to live well. In partnership with Longevity Investors, EYWA creates living ecosystems where architecture, technology, and ancient wisdom converge to elevate human health, measurable wellbeing, and long-term prosperity — translating longevity science directly into the built environment. This is where capital aligns with healthspan infrastructure, and a new category of conscious living begins.
Architecture as a carrier of health — buildings designed from the ground up around the biology of the people inside them
Technology as an amplifier of ancient wisdom — biometric data and natural systems integrated at the design level
Wellbeing as a measurable asset — longevity science embedded in every structural and environmental decision
Community as a protective layer — a curated global ecosystem of health-conscious individuals
IP as scalable value — a multi-platform ecosystem for designing human life, built to grow with the science
What signals should be on our radar?
If you’d like to be featured, spotlight a deal, or explore a partnership, just reply to this email and we’ll take it from there.
We’re all ears on how to make Future Investments News truly indispensable for you -tell us what would make this your go-to read on frontier tech and the next decade of investment. If this issue delivered value, please forward it to a colleague or LP.
Disclaimer
Prepared by Future Investments News for general information only; not investment, legal, or tax advice. No offer or solicitation to buy or sell any security or financial instrument. Past trends and transactions are not reliable indicators of future results. Readers should conduct their own due diligence and consult qualified advisers before making decisions.
Stay ahead,
Future Investments News team.
Future Investments News — Signals shaping the next decade of investment.